These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 2401058

  • 21. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines.
    Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, Ganz P, Selwyn AP.
    Circulation; 1992 Apr; 85(4):1390-7. PubMed ID: 1555281
    [Abstract] [Full Text] [Related]

  • 22. Progression of coronary endothelial dysfunction in man and its potential clinical significance.
    Drexler H, Zeiher AM.
    Basic Res Cardiol; 1991 Apr; 86 Suppl 2():223-32. PubMed ID: 1953614
    [Abstract] [Full Text] [Related]

  • 23. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension.
    Houghton JL, Davison CA, Kuhner PA, Torossov MT, Strogatz DS, Carr AA.
    J Am Coll Cardiol; 1998 Feb; 31(2):374-82. PubMed ID: 9462582
    [Abstract] [Full Text] [Related]

  • 24. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
    Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P.
    Circulation; 1990 Feb; 81(2):491-7. PubMed ID: 2105174
    [Abstract] [Full Text] [Related]

  • 25. Effect of plaque burden on coronary vasoreactivity in early atherosclerosis.
    Manginas A, Voudris V, Pavlides G, Karatasakis G, Athanassopoulos G, Cokkinos DV.
    Am J Cardiol; 1998 Feb 15; 81(4):401-6. PubMed ID: 9485127
    [Abstract] [Full Text] [Related]

  • 26. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis.
    Reddy KG, Nair RN, Sheehan HM, Hodgson JM.
    J Am Coll Cardiol; 1994 Mar 15; 23(4):833-43. PubMed ID: 8106687
    [Abstract] [Full Text] [Related]

  • 27. Coronary segmental responses to acetylcholine and bradykinin in patients with atherosclerotic risk factors.
    Kato M, Shiode N, Yamagata T, Matsuura H, Kajiyama G.
    Am J Cardiol; 1997 Sep 15; 80(6):751-5. PubMed ID: 9315582
    [Abstract] [Full Text] [Related]

  • 28. Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine.
    Tsurumi Y, Nagashima H, Ichikawa K, Sumiyoshi T, Hosoda S.
    J Am Coll Cardiol; 1995 Nov 01; 26(5):1242-50. PubMed ID: 7594038
    [Abstract] [Full Text] [Related]

  • 29. Early impairment of acetylcholine-induced endothelium-dependent coronary vasodilation is not predictive of secondary graft atherosclerosis.
    Aptecar E, Benvenuti C, Loisance D, Cachera JP, Nitenberg A.
    Chest; 1995 May 01; 107(5):1266-74. PubMed ID: 7750317
    [Abstract] [Full Text] [Related]

  • 30. Preserved endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation.
    Sabaté M, Kay IP, van Der Giessen WJ, Cequier A, Ligthart JM, Gómez-Hospital JA, Carlier SG, Coen VL, Marijnissen JP, Wardeh AJ, Levendag PC, Serruys PW.
    Circulation; 1999 Oct 12; 100(15):1623-9. PubMed ID: 10517733
    [Abstract] [Full Text] [Related]

  • 31. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis.
    Zeiher AM, Schächlinger V, Hohnloser SH, Saurbier B, Just H.
    Circulation; 1994 Jun 12; 89(6):2525-32. PubMed ID: 8205660
    [Abstract] [Full Text] [Related]

  • 32. Evidence of partially preserved endothelial dilator function in diseased coronary arteries.
    Tousoulis D, Tentolouris C, Crake T, Stefanadis C, Toutouzas P, Davies G.
    Heart; 1999 Oct 12; 82(4):471-6. PubMed ID: 10490563
    [Abstract] [Full Text] [Related]

  • 33. Paradoxical vasoconstriction as result of acetylcholine and serotonin in diseased human coronary arteries.
    Vrints CJ, Bult H, Bosmans J, Herman AG, Snoeck JP.
    Eur Heart J; 1992 Jun 12; 13(6):824-31. PubMed ID: 1623875
    [Abstract] [Full Text] [Related]

  • 34. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO.
    Circulation; 1995 Aug 01; 92(3):320-6. PubMed ID: 7634444
    [Abstract] [Full Text] [Related]

  • 35. Variations of segmental endothelium-dependent and endothelium-independent vasomotor tone after cardiac transplantation (qualitative changes in endothelial function).
    Weis M, Peter-Wolf W, Mazzilli N, Olbrich HG, Schacherer C, Wiemer J, Burger W, Hartmann A.
    Am Heart J; 1997 Aug 01; 134(2 Pt 1):306-15. PubMed ID: 9313612
    [Abstract] [Full Text] [Related]

  • 36. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
    Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, Iaccarino G, De Bruyne B, Chiariello M, Wijns W.
    Circulation; 2005 Jan 25; 111(3):288-94. PubMed ID: 15642763
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.